#European Platelet Rich Fibrin Market Growth | Explore Tumblr Posts and Blogs

sriramnanda-blog · 4 years

Text

EUROPE PLATELET-RICH PLASMA MARKET ANALYSIS

Europe platelet-rich plasma market is estimated to account for US$ 75.8 Mn in terms of value by the end of 2027.

Europe Platelet-rich Plasma Market: Drivers

Increasing prevalence of musculoskeletal injuries is expected to boost growth of Europe platelet-rich plasma market over the forecast period. For instance, according to the Study, ‘Prevalence of Musculoskeletal Injuries, Pain, and Illnesses in Elite Female Basketball Players, in Europe, in June 2019, the most frequently injured body parts were lower limbs: more than 60%, representing an injury rate of 0.14 per athletes and a 0.2 pain rate per athlete (during the study period).

Moreover, increasing geriatric population and high adoption of knee osteoarthritis treatment in by the age group is also expected to aid in growth of the market. Aging contributes to soft tissue degeneration and related-disorders, particularly of the knee. For instance, according to the study ‘Osteoarthritis in Europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries’ that examined the impact of peripheral joint osteoarthritis across five European countries, UK (43.6%), France, (25.6%), Germany, (15.2%), Spain, (8.4%), and Italy (7.1%) recorded high prevalence of peripheral joint osteoarthritis, with majority of cases aging 55-74 years.

U.K. held dominant position Europe platelet-rich plasma market in 2019, accounting for 23.5% share in terms of valuee, followed by France.

Figure 1. Europe Platelet-rich Plasma Market Value (US$ Mn), by Country/Region, 2019

Europe Platelet-rich Plasma Market: Restraints

Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques is a major factor hindering growth of market. Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques lead in uncertainty about the evidence to support the increasing clinical use of platelet-rich plasma therapy as a treatment modality for musculoskeletal injuries, including orthopedic bone and soft-tissue injuries.

Moreover, uncertainty about therapeutic efficacy of platelet-rich plasma is also expected to hamper growth of the market. For instance, the study ‘Current Clinical Recommendations for Use of Platelet-Rich Plasma’ published in Current Reviews in Musculoskeletal Medicine in 2018, found moderate high-quality evidence that supported the use of leukocyte-rich (LR)-PRP injection for patellar tendinopathy and of PRP injection for plantar fasciitis and donor site pain in patellar tendon graft Bone-patellar tendon-bone anterior cruciate ligament reconstruction. Moreover, the review also noted insufficient evidence to routinely recommend PRP for rotator cuff tendinopathy, osteoarthritis of the hip, or high ankle sprains.

Europe Platelet-rich Plasma Market: Opportunities

Increasing adoption of PRP in skeletal muscle injuries is expected to offer lucrative growth opportunities for players in the market. PRP has promotes muscle recovery via anabolic growth factors released from activated platelets. This in turn reduces pain, swelling, and time for recovery in skeletal muscle injuries.

Kits segment in Europe platelet-rich plasma market was valued at US$ 34.9 Mn in 2019 and is expected to reach US$ 60.4 by 2027 at a CAGR of 7.1% during the forecast period.

Market Trends/Key Takeaways

The demand for pure PRP fibrin therapy has increased significantly in the recent past, especially for the treatment of skin wound ulcers and in oral and maxillofacial surgeries. The platelet-rich fibrin therapy is classified as a second generation platelet concentrate, with rich platelet content and extensive growth factors in the form of fibrin membranes, which are free of any anti-coagulants or other artificial bio-chemical modifications and promote rapid and accelerated wound healing.

Increasing geriatric population in Europe has led to high demand for non-invasive or minimally invasive surgical treatments. PRP therapy is a simple, efficient, and minimally invasive procedure that represents an appropriate biological approach for ensuring tissue regeneration in a very short period of time. Such scenario has led to high adoption of PRP therapy for the treatment of orthopedic related injuries in geriatric patients.

Regulations

Europe

Directive 2002/98/EC of the European Parliament and Council of January 27, 2003, regulates the approval process for blood and blood-derived products

Harmonized regulatory framework for PRP therapies is not present

Devices must comply with Class II- medical device directive 93/42/EEC.

This committee is engaged in the establishment of quality, safety, and efficacy of blood products and in setting norms for collection, processing, and distribution of blood components across the European Union countries

Each country has its own approach to PRP regulation within the jurisdiction of national authorities

Device approval is overseen in each EU country by a governmental body called a ‘Competent Authority.’

The surgical use of PRP can be considered as an autologous graft within the surgical procedure as regulated by Directive 2004/23/EC

Europe Platelet-rich Plasma Market: Competitive Landscape

Europe Platelet-rich Plasma Market: Key Developments

In January 2020, SHVI PRP Therapy, announced a new website that is focused specifically at the use of PRP to mitigate hair loss.

In January 2019, Generex Biotechnology Corporation entered into a letter of intent to acquire Medisource Partners, an FDA-registered distributor of medical and surgical products including supplies kits to process bone marrow aspirates and PRP biologics at the time of surgery.

In December 2018, Regenexx’s research published in the Journal of Translational Medicine, which involved use of patients' own bone marrow concentrate and PRP products demonstrated positive clinical outcomes for the treatment of osteoarthritis of the knee.

About Us- Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: Customized Market Research Services Industry Analysis Services Business Consulting Services Market Intelligence Services Long term Engagement Model Country Specific Analysis Mr. Shah

Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1–206–701–6702 Email: [email protected]

#EUROPE PLATELET-RICH PLASMA MARKET ANALYSIS #platelet-rich plasma #platelet-rich plasma market analysis #europe market analysis

0 notes

fmireports2020 · 4 years

Text

Europe Platelet Rich Plasma (PRP) Market Pegged for Robust Expansion By 2024

Future Market Insights offers 8-year forecast on the Europe PRP Market between 2016 and 2024. In terms of value, the PRP market is expected to register a CAGR of 6.6% during the forecast period. This study demonstrates market dynamics and trends in EU5 and rest of European countries that are expected to influence the current environment and future status of the Europe PRP market over the forecast period.

Report Description

This Future Market Insights report examines the PRP market for the period 2016–2024. The primary objective of the report is to offer insights into developments in the PRP market that are significantly helping transform the healthcare industry into a more comprehensive industry.

The Europe PRP market report begins by defining ‘PRP’ and its types. It also lists the various application for PRP therapy. This is followed by an overview of the Europe PRP market. The overview section includes FMI’s analysis of the key trends, drivers, restraints, trends and opportunities that are influencing growth of PRP market currently. Impact analysis of the key growth drivers and restraints based on the weighted average model has also been included in the ‘European Platelet Rich Plasma (PRP) Market’ to better equip customers and readers with country specific trends and insights.

The primary driving factors for the PRP market are significant increase in the number of sports injuries, rising prevalence of musculoskeletal injuries, progressive demographic ageing of the older population and technological advancements in PRP therapy to improve success and recovery rate. Furthermore, increase in demand of PRP therapy in sports injuries and ease in regulatory approvals has also triggered growth of the Europe PRP market.

To get the sample copy of report visit @ https://www.futuremarketinsights.com/reports/sample/rep-eu-1599

On the basis of product type, the Europe PRP market is segmented into instruments and kits product type segment. Furthermore, kits product type segment is further sub-segmented into P-PRP kits, L-PRP kits, L-PRF kits and P-PRF kits based on end product type and into autologous - PRP kits, homologous - PRP kits, and allogeneic - PRP kits based on the source of blood. Secondly, the market is also segmented based on application in orthopaedic industry. A detailed analysis of all the categories of application has been provided in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The next section of the report highlights the PRP market by country. It provides the market outlook for 2016–2024 and sets the forecast within the context of the PRP market. The study discusses the key regional trends and contracts contributing to growth of the PRP market in European region, as well as analyses the extent to which the drivers are influencing this market in this region. Key country assessed in this report include the U.K., Germany, France, Italy, Spain and rest of Europe.

The above sections – by product type, application, and country – evaluate the present scenario and growth prospects of the PRP market for the period 2016–2024. We have considered 2015 as the base year and provided data for the forecast period, i.e. 2016–2024.

Request for Covid-19 Impact Analysis @ https://www.futuremarketinsights.com/covid19/rep-eu-1599

The forecast presented here assesses the total revenue generated across the PRP market in Europe region over the forecast period. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the PRP market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis, i.e. by supply side, downstream industry demand and the economic envelope.

It is imperative to note that in an ever-fluctuating European economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters, such as Year-on-Year (Y-o-Y) growth rates, to understand the predictability of the market and to identify the right opportunities in it.

The PRP market segments in terms of products, application and countries are analysed on the basis of their respective Basis Point (BPS) to understand the individual segment’s relative contribution to market growth. This detailed level of information is important for the identification of various key trends in the PRP market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the PRP market.

Download Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-eu-1599

To understand key growth segments, Future Market Insights developed the PRP market ‘Attractiveness Index’. The resulting index helps providers to identify real market opportunities.

In the final section of the report on the PRP market, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, to access the key differentiators among the competitor firms. Key categories of providers covered in the report are instruments and kits. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the PRP value chain and the potential players with regard to the same. However, this section also includes market strategies and SWOT analysis of the main players in the market.

Detailed profiles of the medical device companies are also included in the scope of the report to evaluate their long-term and short-term strategies. Key players in the market include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd, Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., and Regen Lab S.A.

Key Segments Covered

Product Type

By Application

Instruments

Kits

Kits BY Type

Kits BY Origin

Pure Platelet-Rich Plasma (P-PRP)

Leukocyte-Rich Platelet-Rich Plasma (L-PRP)

Leukocyte-Platelet-Rich Fibrin (L-PRF)

Pure Platelet-Rich Fibrin (P-PRF)

Autologous Platelet-Rich Plasma

Homologus Platelet-Rich Plasma

Allogeneic Platelet-Rich Plasma

Knee

Elbow

Foot and Ankle

Shoulder

CMF

Others

Key Countries Covered

Europe

The U.K.

France

Germany

Spain

Italy

Rest of Europe

Key Companies

Arthrex, Inc.

Stryker Corporation

Johnson and Johnsons Ltd

Zimmer Biomet Holdings Inc.

Terumo Corporation

Glofinn Oy

Medira Ltd.

Regen Lab S.A.

#Europe Platelet Rich Plasma (PRP) Market

0 notes

technicallyyoungkitten · 4 years

Text

Europe Platelet rich Plasma Market Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood. It is used to accelerate the healing of injured tendons, ligaments, muscles and joints.Europe platelet-rich plasma market is estimated to account for US$ 75.8 Mn in terms of value by the end of 2027.

Browse Summary of the Research Report– https://www.coherentmarketinsights.com/market-insight/europe-platelet-rich-plasma-market-3346

U.K. held dominant position Europe platelet-rich plasma market in 2019, accounting for 23.5% share in terms of valuee, followed by France.Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques is a major factor hindering growth of market. Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques lead in uncertainty about the evidence to support the increasing clinical use of platelet-rich plasma therapy as a treatment modality for musculoskeletal injuries, including orthopedic bone and soft-tissue injuries.

Moreover, technological advancements in PRP such as changes in production protocol (time and RPM/centrifugal force) and output level (volume and concentration above baseline) are also expected to aid in growth of the market.Kits segment in Europe platelet-rich plasma market was valued at US$ 34.9 Mn in 2019 and is expected to reach US$ 60.4 by 2027 at a CAGR of 7.1% during the forecast period.

Directive 2002/98/EC of the European Parliament and Council of January 27, 2003, regulates the approval process for blood and blood-derived productsThis committee is engaged in the establishment of quality, safety, and efficacy of blood products and in setting norms for collection, processing, and distribution of blood components across the European Union countries

Major players operating in Europe include, Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., and Estar Technologies Ltd.In January 2020, SHVI PRP Therapy, announced a new website that is focused specifically at the use of PRP to mitigate hair loss.

In March 2019, CollPlant, a regenerative medicine company, renewed its exclusive distribution agreement with Arthrex for Vergenix STR, an injectable gel comprised of cross-linked bioengineered recombinant human type I collagen, rhCollagen, combined with autologous PRP, for the treatment of tendinopathy.In January 2019, Generex Biotechnology Corporation entered into a letter of intent to acquire Medisource Partners, an FDA-registered distributor of medical and surgical products including supplies kits to process bone marrow aspirates and PRP biologics at the time of surgery.

Request A Sample Copy link:- https://www.coherentmarketinsights.com/insight/request-sample/3346

Mr.Shah Coherent Market ,Insights 10014thAve, #3200 Seattle,WA98154 Tel:+1-206-701-6702 Email: [email protected]

************************************************************************************

0 notes

healthy-insights · 7 years

Text

Platelet Rich Plasma Market is Set to Garner Staggering Revenues By 2022

A new Transparency Market Research report states that the Europe Platelet Rich Plasma Market stood at US$42.1 mn in 2013 and is predicted to reach US$ 87.2 mn in 2022. It is expected to expand at a CAGR of 8.30% from 2014 to 2022. The title of the report is, “Platelet Rich Plasma Market - Europe Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 – 2022”.

According to the report, the platelet rich plasma market in Europe is driven by the rising incidence of sports injuries; diseases including orthopedic diseases, neurological diseases, cardiovascular diseases; and obesity. In addition, the growing geriatric population being more prone to surgeries and injuries has also boosted the market. Furthermore, factors such as the launch of numerous devices for the preparation of platelet rich plasmas and the increasing awareness about the platelet rich plasma therapy and its benefits have also impacted the market positively. On the other hand, the factors such as the soaring costs of therapies and devices and the chances of treatment failures are amongst the key factors that may impede the growth of the market.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4761

On the basis of type, the platelet rich plasma market in Europe is segmented into pure-platelet rich plasma (P-PRP), leukocyte-platelet rich fibrin (L-PRF), and leukocyte-platelet rich plasma (L-PRP). Amongst these, the segment of P-PRP led the market in 2013 and constituted a share of 70.8% in the market in Europe. This is owing to the rich platelet content of P-PRP. On the other hand, the segment of L-PRF is anticipated to experience the fastest growth rate in the forecast horizon owing to its benefits such as ease of preparation, reduced healing time of wounds, and cost-effectiveness, etc.

On the basis of origin, the market is segmented into homologous, autologous, and allogenic. Amongst these, in 2013, the segment of autologous led the platelet rich plasma market in Europe. On the other hand, the segment of allogenic platelet rich plasma will also grow owing to its requirement in patients diagnosed with blood disorders such as hemocytopenia and leukemia with a low count of platelets in the blood.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4761

On the basis of application, the market is segmented into cosmetic surgery, orthopedic surgery, general surgery, neurosurgery, and other surgeries such as cardiothoracic, urological, and periodontal. Amongst these, in 2013, the orthopedic surgery application segment led the market and represented 38.3% in the market. This is due to the increasing geriatric population and the rising count of sports and orthopedic injuries in Europe. In addition, platelet rich plasmas are also widely used in cosmetic surgeries in facelift treatments and facial aesthetics within the European region.

Geographically, the platelet rich plasma market in Europe is segmented into Italy, the UK, France, Spain, Germany, and Rest of Europe. Amongst these, the UK held the largest share in the market in 2013 owing to the increasing prevalence of reconstructive and orthopedic procedures in the country. In addition, the rising inclination towards platelet rich plasma therapies for sports injuries will also augment the development of the market in the UK.

Enquiry for discount on this report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4761

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes

markengine-blog · 7 years

Text

Platelet Rich Plasma (PRP) Market Europe Industry Analysis and Opportunity

Future Market Insights offers 8-year forecast on the Europe PRP market between 2016 and 2024. In terms of value, the PRP market is expected to register a CAGR of 6.6% during the forecast period. This study demonstrates market dynamics and trends in EU5 and rest of European countries that are expected to influence the current environment and future status of the Europe PRP market over the forecast period.

Request For Sample Report : http://www.mrrse.com/sample/2054

Report Description

Send An Enquiry : http://www.mrrse.com/enquiry/2054

To understand key growth segments, Future Market Insights developed the PRP market ‘Attractiveness Index’. The resulting index helps providers to identify real market opportunities.

Browse Full Report With TOC : http://www.mrrse.com/europe-platelet-rich-plasma-market

Key Segments Covered

Product Type

Instruments

Kits

Kits BY Type

Pure Platelet-Rich Plasma (P-PRP)

Leukocyte-Rich Platelet-Rich Plasma (L-PRP)

Leukocyte-Platelet-Rich Fibrin (L-PRF)

Pure Platelet-Rich Fibrin (P-PRF)

Kits BY Origin

Autologous Platelet-Rich Plasma

Homologus Platelet-Rich Plasma

Allogeneic Platelet-Rich Plasma

By Application

Knee

Elbow

Foot and Ankle

Shoulder

CMF

Others

Key Countries Covered

Europe

The U.K.

France

Germany

Spain

Italy

Rest of Europe

Key Companies

Arthrex, Inc.

Stryker Corporation

Johnson and Johnsons Ltd

Zimmer Biomet Holdings Inc.

Terumo Corporation

Glofinn Oy

Medira Ltd.

Regen Lab S.A.

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower 90, State Street Suite 700 Albany, NY - 12207 United States

Telephone: +1-518-730-0559 Email: [email protected]

Google+: https://plus.google.com/u/0/109558601025749677847/posts

Linked in: https://www.linkedin.com/company/mrrse

Twitter: https://twitter.com/MRRSEmrrse

0 notes

healthy-insights · 7 years

Text

Platelet Rich Plasma Market Growth, Trends and Forecast up to 2022

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4761

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4761

Purchase this Report @

https://www.transparencymarketresearch.com/checkout.php?rep_id=4761&ltype=S

About Us

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes